Last evening on the CBS Nightly News, Armen Keteyian reported on a longstanding problem at nursing homes.
The report by the Health and Human Services inspector general also found that antipsychotic drugs were given to nursing home residents "unnecessarily" over 300,000 times between January and June 2007, with more than half of those drugs (150,106) given "in excessive dose."
"The use of anti-psychotic drugs when they are not necessary is a form of restraint," said Dr. David Zimmerman, University of Wisconsin. "It's a form of chemical restraint."
The Department of Health and Human Services also says it's "very concerned" that there are "financial incentives for unnecessary drug use." In the past those incentives have led to charges of "kickbacks" between nursing homes, pharmacies and a drug company.
The newer class of drugs, atypical antipsychotics, such as Zyprexa (Eli Lilly & Co.) and Risperdal (Johnson & Johnson), already received the stronger warning labels in 2005, alerting the public about the potential for heart attack and pneumonia when given to the elderly.
This clearly links to the issue of financial incentives to nursing homes and Big PhRMA kickbacks.
What was also strange was that they had no drug interaction profile for the drugs. The DON offered the excuse that their pharmacy did this. However, they would not identify the pharmaceutical supplier of their drugs, or supply me with any related data.
9:31 AM
ari sari
Posted in: 

